Source Citation

The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-27. https://pubmed.ncbi.nlm.nih.gov/17494925

Clinical Impact Ratings

GIM/FP/GP: 6 out of 7

Infectious Disease: 6 out of 7

Public Health: 6 out of 7

Reference

  • 1 Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13:28-41. [PMID: 17370513] Google Scholar

IMPORTANT: This site is undergoing maintenance for the next 24 hours, starting 3/29/21 at 7:00 PM EDT. Individual users will not be able to log into their accounts to comment
on articles or take CME. Institutional administrators will not be able to make changes. Contact [email protected] with questions.